R35GM140631
Project Grant
Overview
Grant Description
The biology of motile cilia - Cilia are microtubule-based cellular extensions that play key roles in sensing the extracellular environment, processing developmental signals, and generating propulsive force and fluid flow. They also act as secretory organelles, releasing bioactive vesicular ectosomes involved in cell-cell communication and other processes. Cilia are ancient and complex; in humans, approximately 5% of all genes are involved in their formation/activity, and defects result in complex syndromes or ciliopathies.
For many years, my laboratory has been broadly interested in the assembly and function of motile cilia and has a strong record of identifying new opportunities and pursuing them to reveal novel aspects of ciliary biology. Most recently, we demonstrated that cilia act as a source of peptidergic signals. For most studies, we utilize the biciliate unicellular green alga Chlamydomonas as a model due to the ease of biochemical analysis and large array of molecular genetic approaches available.
Over the next five years, we will pursue two broad areas of focus to address what I consider key questions in ciliary biology. Although superficially distinct, these two areas are intimately connected, and I anticipate we will be able to integrate them to yield novel insights into conserved and essential cilia-based pathways.
1) Ciliary Motility: Dissecting the dynein motors and control systems that generate ciliary beating and power retrograde intraflagellar transport (IFT). We plan to focus on three major issues. We will dissect the complex pathways by which axonemal and IFT dyneins are synthesized and assembled in the cytoplasm, employing our newly devised biochemical fractionation methods. Building a cilium is an immensely complex problem in macromolecular assembly, and we will examine how assembly factors control the axonemal incorporation of outer dynein arms at precise locations on doublet microtubules. We will also study axonemal dynein motor regulation to a) determine how responses to alterations in Ca2+ and redox poise are combined with curvature sensing to yield integrated changes in motility, and b) assess how cells sense imposed changes in ciliary beating and respond by increasing intraciliary levels of the dynein regulator LIS1.
2) Cilia Formation and Peptidergic Signaling: Studying the peptide amidating enzyme (peptidylglycine-amidating monooxygenase; PAM) and its amidated bioactive products in ciliary assembly and cilia-based cell-cell communication. We recently demonstrated that active PAM occurs in cilia and that PAM loss leads to the failure of ciliogenesis and disrupts dynein-driven retrograde IFT. Furthermore, PAM-generated amidated bioactive products are released in cilia-derived vesicular ectosomes, and one acts as a chemotactic modulator. We will build on these observations to identify novel amidated PAM products involved in cilia formation. We will dissect the pathways leading to regulated amidated product release in ciliary ectosomes and determine where/when processing of the precursors occurs. We will also pursue the amidated product receptors and their downstream signaling pathways, which lead to differential regulation of the two motile cilia and chemotaxis.
For many years, my laboratory has been broadly interested in the assembly and function of motile cilia and has a strong record of identifying new opportunities and pursuing them to reveal novel aspects of ciliary biology. Most recently, we demonstrated that cilia act as a source of peptidergic signals. For most studies, we utilize the biciliate unicellular green alga Chlamydomonas as a model due to the ease of biochemical analysis and large array of molecular genetic approaches available.
Over the next five years, we will pursue two broad areas of focus to address what I consider key questions in ciliary biology. Although superficially distinct, these two areas are intimately connected, and I anticipate we will be able to integrate them to yield novel insights into conserved and essential cilia-based pathways.
1) Ciliary Motility: Dissecting the dynein motors and control systems that generate ciliary beating and power retrograde intraflagellar transport (IFT). We plan to focus on three major issues. We will dissect the complex pathways by which axonemal and IFT dyneins are synthesized and assembled in the cytoplasm, employing our newly devised biochemical fractionation methods. Building a cilium is an immensely complex problem in macromolecular assembly, and we will examine how assembly factors control the axonemal incorporation of outer dynein arms at precise locations on doublet microtubules. We will also study axonemal dynein motor regulation to a) determine how responses to alterations in Ca2+ and redox poise are combined with curvature sensing to yield integrated changes in motility, and b) assess how cells sense imposed changes in ciliary beating and respond by increasing intraciliary levels of the dynein regulator LIS1.
2) Cilia Formation and Peptidergic Signaling: Studying the peptide amidating enzyme (peptidylglycine-amidating monooxygenase; PAM) and its amidated bioactive products in ciliary assembly and cilia-based cell-cell communication. We recently demonstrated that active PAM occurs in cilia and that PAM loss leads to the failure of ciliogenesis and disrupts dynein-driven retrograde IFT. Furthermore, PAM-generated amidated bioactive products are released in cilia-derived vesicular ectosomes, and one acts as a chemotactic modulator. We will build on these observations to identify novel amidated PAM products involved in cilia formation. We will dissect the pathways leading to regulated amidated product release in ciliary ectosomes and determine where/when processing of the precursors occurs. We will also pursue the amidated product receptors and their downstream signaling pathways, which lead to differential regulation of the two motile cilia and chemotaxis.
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Farmington,
Connecticut
06030
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 699% from $428,978 to $3,428,570.
University Of Connecticut Health Center was awarded
Ciliary Biology: Motile Cilia Assembly & Function
Project Grant R35GM140631
worth $3,428,570
from the National Institute of General Medical Sciences in May 2021 with work to be completed primarily in Farmington Connecticut United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity Maximizing Investigators' Research Award (R35 - Clinical Trial Optional).
Status
(Ongoing)
Last Modified 4/25/25
Period of Performance
5/1/21
Start Date
4/30/26
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Transaction History
Modifications to R35GM140631
Additional Detail
Award ID FAIN
R35GM140631
SAI Number
R35GM140631-709530773
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
H6D6JMXJXDE6
Awardee CAGE
1G782
Performance District
CT-05
Senators
Richard Blumenthal
Christopher Murphy
Christopher Murphy
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,499,796 | 100% |
Modified: 4/25/25